Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › TARA

SUPERSTRING CAPITAL MANAGEMENT LP position in TARA

PROTARA THERAPEUTICS INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 121,457 shares of TARA (PROTARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$464K, representing 0.29% of its reported portfolio and ranking #28 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TARA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)121.46K sh
Reported value held$463.97K
Portfolio Weight0.29%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's TARA position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in TARA in Q4 2024 at 360,000 shares (US$1.9M). The position peaked in Q4 2025 at 360,000 shares, worth US$1.9M. Across 7 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 121,457 shares valued at US$464K. Notable position changes include a 66% trim in Q1 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 360.00K $1.90M New
Q1 2025 360.00K $1.53M Hold
Q2 2025 360.00K $1.09M Hold
Q3 2025 360.00K $1.57M Hold
Q4 2025 360.00K $1.92M Hold
Q1 2026 121.46K $632.79K Reduce
Q2 2026 121.46K $463.97K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARA and 13F data

TARA (PROTARA THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in TARA — the largest reported positions include Velan Capital Investment Management LP (US$10.9M), Sio Capital Management, LLC (US$7.3M), ACORN CAPITAL ADVISORS, LLC (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARA

All TARA fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held TARA?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TARA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in TARA?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 121.46K shares of TARA (PROTARA THERAPEUTICS INC), valued at $463.97K, representing 0.29% of its reported portfolio and ranking #28.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling TARA?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP held unchanged its position in TARA. The position peaked in Q4 2025 at 360.00K shares.

Which other funds hold TARA?

Other major institutional holders of TARA include Velan Capital Investment Management LP, Sio Capital Management, LLC, ACORN CAPITAL ADVISORS, LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.